This paper compared plasma metabolome results obtained by high-performance liquid chromatography/quadruple time-of-flight mass spectrometry (HPLC-QTOF-MS) from venous and arterial blood collected in Streck and sodium heparin tubes from male and female patients with suspected lung cancer. Additionally, the metabolome was compared among plasma specimens collected from patients diagnosed with acinar adenocarcinoma, adenocarcinoma, squamous cell carcinoma and benign lung conditions.
Comparative metabolomics studies of blood collected in streck and heparin tubes from lung cancer patients.
Goldberg E, Ievari-Shariati S, Kidane B, Kim J, Banerji S, Qing G, Srinathan S, Murphy L, Aliani M
Purpose
Conclusion
A total of 1,569 and 1,787 metabolites were identified in ESI positive and negative mode, respectively. Of these, 96 metabolites were influenced by patient sex, collection tube type, and/or sampling location. 56 metabolites differed in plasma specimens collected from male and female patients, and collection location had a confounding effect on 8 of these metabolites. A total of 33 metabolites differed between sodium heparin and Streck plasma, of which 18 were higher and 15 were lower in the Streck tube than the sodium heparin tube; generally, intensities were higher in the Streck specimen. Hierarchical clustering based on the 96 metabolites differentially expressed between patient sex, collection tube type, and/or sampling location clustered specimens first by tube type, then patient sex. In principal component analysis (PCA), 90.48% of the variability in the first two factors was explained by tube type, with close proximity of the two ESI polarity centroids.
A total of 130 metabolites displayed significant differences when plasma from patients with different diagnoses were compared; metabolite differences relative to plasma from patients diagnosed with a benign mass had a greater degree of commonality among plasma collected from acinar adenocarcinoma and adenocarcinoma than plasma from adenocarcinomas and squamous cell carcinoma. A partial least square discrimination test based on these 130 metabolites had a diagnostic accuracy of 81%. Correlations were observed for these 130 metabolites between the cancer subtypes in both the ESI positive and negative modes.
Studies (1)
Purpose
This study compared plasma metabolome results from venous and arterial blood collected in Streck and sodium heparin tubes from male and female patients with suspected lung cancer. Additionally, the metabolome was compared among specimens from patients diagnosed with acinar adenocarcinoma, adenocarcinoma, squamous cell carcinoma, and benign lung conditions. Blood was collected from 42 patients (21 male and 21 female; 25-83 years of age; 6 never smokers, 9 current smokers, and 27 prior smokers) with suspected lung cancer at the time of surgery; blood was collected both from an indwelling radial arterial line and via venipuncture into Streck BCT or sodium heparin Vacutainer tubes. Tubes were inverted 3-4 times before plasma separation by centrifugation at 450 g for 10 minutes at room temperature. Plasma was aliquoted and frozen at -80°C within 2 h of blood collection. Metabolites were extracted with acetonitrile, vortexed, centrifuged at 10,000 g for 10 minutes at 4˚C, and the supernatant was dried under nitrogen in a nitrogen evaporator. Dried extracts were stored at -20˚C until using a Rapid Resolution HPLC system coupled to a 6538 UHD Accurate LC- QTOF-MS with a dual electrospray ionization (ESI) source. Total ion current chromatograms were generated from raw data with Agilent Mass Hunter Qualitative Version B.07 software.
Summary of Findings
A total of 1,569 and 1,787 metabolites were identified in the ESI positive and negative mode, respectively, with 96 metabolites significantly affected by patient sex, collection tube type, and/or sampling location. Of these 96 metabolites, 56 differed in specimens from male and female patients, and collection location had a confounding effect on 8 of these metabolites. A total of 33 metabolites differed between sodium heparin and Streck plasma, of which 18 were higher and 15 lower in the Streck tube than the sodium heparin tube; however, intensities were generally higher in the Streck specimen. Allantoin levels were higher and pyridinoline levels were lower when blood was collected in Streck tubes compared to sodium heparin tubes. Hierarchical clustering based on the 96 metabolites differentially expressed between patient sex, collection tube type, and/or sampling location clustered specimens first by tube type, then patient sex. In principal component analysis (PCA), 90.48% of the variability in the first two factors was explained by tube type, and the two ESI polarity centroids were in close proximity to each other. Levels of carboxylic acids (Met Cys, Tyr Met, nitrotyrosine), dithianes (dimethyl-dithiane-diol), dimethachlor (herbicide) purine nucleotides (Oxo-dGMP), organooxygen compounds (urochloralic acid, erythritol), pyridine nucleotides (nicotinamide ribotide), dithianes (dimethyl-dithiane-diol), and benzene (treprostinol) were higher in Streck plasma than sodium heparin plasma, and levels of two isomers of PS 34:1, dopamine, and glucose were all higher in sodium heparin plasma than Streck plasma.
Based on histological analysis, 22 patients were diagnosed with adenocarcinoma (7 acinar adenocarcinoma, 7 adenocarcinoma and 8 other adenocarcinomas), 11 patients were diagnosed with squamous cell carcinoma, 2 patients with carcinoid tumors, 4 patients had metastasis of other cancers, and 3 patients had benign tumors. A total of 130 metabolites displayed significant differences when plasma from patients with different diagnoses were compared; metabolite differences relative to plasma from patients diagnosed with a benign mass had a greater degree of commonality among plasma collected from acinar adenocarcinoma and adenocarcinoma than plasma from adenocarcinomas and squamous cell carcinoma. A partial least square discrimination test based on these 130 metabolites had a diagnostic accuracy of 81%. Correlations were observed for these 130 metabolites between the cancer subtypes in both the ESI positive and negative modes.
Biospecimens
FluidBloodFluidPlasmaPreservation Types
Streck/BCTFrozenDiagnoses
NeoplasticCarcinomaNeoplasticBenignPlatforms
CarbohydrateLC-MS or LC-MS/MSSteroidLC-ESI-MS/MSSmall moleculeLC-ESI-MS/MSPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Diagnosis/ patient condition Acinar adenocarcinomaAdenocarcinomaBenignSquamous cell carcinomaPreaquisition Patient gender FemaleMaleBiospecimen Acquisition Biospecimen location ArteryVenousBiospecimen Acquisition Method of fluid acquisition Arterial catheterVenipunctureBiospecimen Acquisition Type of collection container/solution Sodium heparin vacutainerStreck tube